A new study reveals that the human body’s immune response to COVID-19 may vary significantly depending on pre-existing conditions, particularly those affecting blood cells. Researchers found that individuals with certain blood-related disorders exhibited weaker antibody production and altered immune cell activity after vaccination or infection. The findings suggest potential vulnerabilities in how these patients respond to the virus, raising questions about tailored treatment approaches. Experts emphasize the need for further investigation to better understand and address these differences in immune protection.